98 related articles for article (PubMed ID: 186537)
1. Use of silica to identify host mechanisms involved in suppression of established Friend virus leukemia.
Wirth JJ; Levy MH; Wheelock EF
J Immunol; 1976 Dec; 117(6):2124-30. PubMed ID: 186537
[TBL] [Abstract][Full Text] [Related]
2. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Pettey CL; Collins JJ
Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
[TBL] [Abstract][Full Text] [Related]
3. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
[TBL] [Abstract][Full Text] [Related]
4. A radiosensitive T-lymphocyte associated with resistance of DBA/2 mice harboring Friend leukemia virus-dormant infections to transplantable Friend leukemia virus-erythroleukemia cells.
DiCicco LM; Truitt GA; Wheelock EF
Cancer Res; 1986 Jan; 46(1):127-32. PubMed ID: 3509990
[TBL] [Abstract][Full Text] [Related]
5. Depression of humoral immunity to sheep erythrocytes in vitro by Friend virus leukemic spleen cells: induction of resistance by statolon.
Weislow OS; Wheelock EF
J Immunol; 1975 Jan; 114(1 Pt 1):211-5. PubMed ID: 1089711
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Friend virus antigen-modulated erythroleukemic cells to lysis by T lymphocytes from mice with dormant Friend virus infections.
Genovesi EV; Marx PA; Wheelock EF
J Immunol; 1979 Mar; 122(3):795-800. PubMed ID: 312825
[TBL] [Abstract][Full Text] [Related]
7. Absence of macrophage involvement in the passive serum therapy of Friend leukemia virus-induced disease.
Collins JJ; Snyderman R
Cancer Res; 1980 Mar; 40(3):557-62. PubMed ID: 6258783
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal interference between milk-transmitted mammary tumor virus and Friend leukemia viruses in mice: possible role of the interferon system.
Basolo F; Toniolo A; Bistocchi M; Fontanini G; Squartini F
Cancer Res; 1986 Aug; 46(8):4064-70. PubMed ID: 2425940
[TBL] [Abstract][Full Text] [Related]
9. Cellular and serum involvement in protection against Friend leukemia virus.
Schuller GB; Morahan PS
Cancer Res; 1977 Nov; 37(11):4064-9. PubMed ID: 908040
[TBL] [Abstract][Full Text] [Related]
10. Impaired macrophage function in Friend virus leukemia: restoration by statolon.
Levy MH; Wheelock EF
J Immunol; 1975 Mar; 114(3):962-5. PubMed ID: 1167568
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia.
Kitagawa M; Matsubara O; Kasuga T
Cancer Res; 1986 Jun; 46(6):3034-9. PubMed ID: 2870802
[TBL] [Abstract][Full Text] [Related]
12. Suppression of extablished Friend virus leukemia by statolon: potentiation of statolon's leukemosuppressive activity by chlorite-oxidized oxyamylose.
Weislow OS; Wheelock EF
Infect Immun; 1975 Jan; 11(1):129-36. PubMed ID: 1090523
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of murine leukemia. XI. differential susceptibility of spleen cells from serum-protected mice to the in vitro immunosuppressive effects of Friend leukemia virus-infected splenocytes.
Pettey CL; Collins JJ
Int J Cancer; 1984 Aug; 34(2):269-76. PubMed ID: 6540757
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous silica on immune and non-immune functions of the murine host.
Levy MH; Wheelock EF
J Immunol; 1975 Jul; 115(1):41-8. PubMed ID: 239057
[TBL] [Abstract][Full Text] [Related]
15. Effects of Friend leukemia virus (FLV) inoculation in F1 mice and differentiation of FLV-induced leukemia.
Kitagawa M; Matsubara O; Kasuga T
Histol Histopathol; 1986 Oct; 1(4):335-40. PubMed ID: 2980128
[TBL] [Abstract][Full Text] [Related]
16. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
Afifi MS; Bennett M; Kumar V
Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
[TBL] [Abstract][Full Text] [Related]
17. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
18. Influence of immune stimulators on viral leukemogenesis.
Marx PA; Wheelock EF
Ann N Y Acad Sci; 1976; 276():502-12. PubMed ID: 1071975
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous regression of Friend virus-induced erythroleukemia. III. The role of macrophages in regression.
Marcelletti J; Furmanski P
J Immunol; 1978 Jan; 120(1):1-8. PubMed ID: 203629
[TBL] [Abstract][Full Text] [Related]
20. Induction of leukemia regression in mice by immunotherapeutic transfer of T-lymphocytes.
Johnson CS; Thurlow SM; Furmanski P
Cancer Res; 1986 Jan; 46(1):183-9. PubMed ID: 3079585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
